Pharmaceutical Domain Faces Challenges Amid Patent Expirations and Policy Shifts
Published on: March 20, 2026, 2:29 a.m. | Source: Devdiscourse
The health sector is facing significant changes with patent cliffs, regulatory updates, and pricing policy adjustments. The FTC monitors drug company practices as key patents expire, while the FDA pushes for non-animal testing innovations. Global pricing debates and competitive markets exemplify the sector's dynamic landscape, impacting consumers and corporations.
